Deep Brain Stimulation Devices Market Statistics – 2030

Deep Brain Stimulation Devices Market - By Application (Parkinsons Disease, Epilepsy, Essential Tremor, Obsessive-Compulsive Disorder, Dystonia, Pain Management, Others), By End-use (Hospitals, Ambulatory Surgical Centers) & Forecast, 2022-2030

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology

1.1&nbsp;&nbsp;&nbsp; Market definitions

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; working

1.3&nbsp;&nbsp;&nbsp; Forecast parameters

1.4&nbsp;&nbsp;&nbsp; Data validation

1.5&nbsp;&nbsp;&nbsp; Data sources

1.5.1&nbsp;&nbsp;&nbsp; Secondary

1.5.1.1&nbsp;&nbsp;&nbsp;Paid sources

1.5.1.2&nbsp;&nbsp;&nbsp;Unpaid sources

1.5.2&nbsp;&nbsp;&nbsp; Primary

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Deep brain stimulation devices industry 3600 synopsis, 2017 - 2030

2.1.1&nbsp;&nbsp;&nbsp; Business trends

2.1.2&nbsp;&nbsp;&nbsp; Application trends

2.1.3&nbsp;&nbsp;&nbsp; End-use trends

2.1.4&nbsp;&nbsp;&nbsp; Regional trends

Chapter 3&nbsp;&nbsp;&nbsp;Deep Brain Stimulation Devices Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry segmentation

3.2&nbsp;&nbsp;&nbsp; Industry landscape, 2017 &ndash; 2030 (USD Million)

3.3&nbsp;&nbsp;&nbsp; Industry impact forces

3.3.1&nbsp;&nbsp;&nbsp; Growth drivers

3.3.1.1&nbsp;&nbsp;&nbsp;Increasing demand for minimally invasive surgery in developed countries

3.3.1.2&nbsp;&nbsp;&nbsp;Rising prevalence of neurological disorders globally

3.3.1.3&nbsp;&nbsp;&nbsp;Technological advancements in deep brain stimulation devices

3.3.1.4&nbsp;&nbsp;&nbsp;Increasing number of elderly patients with neurological disorders

3.3.2&nbsp;&nbsp;&nbsp; Restraints

3.3.2.1&nbsp;&nbsp;&nbsp;Complications associated with deep brain stimulation

3.3.2.2&nbsp;&nbsp;&nbsp;Lack of skilled healthcare practitioners

3.4&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4.1&nbsp;&nbsp;&nbsp; By application

3.4.2&nbsp;&nbsp;&nbsp; By end-use

3.5&nbsp;&nbsp;&nbsp; COVID-19 impact analysis

3.6&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.7&nbsp;&nbsp;&nbsp; Competitive landscape, 2021

3.8&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Deep Brain Stimulation Devices, By Application

4.1&nbsp;&nbsp;&nbsp; Key segment trends

4.2&nbsp;&nbsp;&nbsp; Parkinson&#39;s disease

4.2.1&nbsp;&nbsp;&nbsp; Market size, by region, 2017-2030 (USD Million)

4.3&nbsp;&nbsp;&nbsp; Epilepsy

4.3.1&nbsp;&nbsp;&nbsp; Market size, by region, 2017-2030 (USD Million)

4.4&nbsp;&nbsp;&nbsp; Essential tremor

4.4.1&nbsp;&nbsp;&nbsp; Market size, by region, 2017-2030 (USD Million)

4.5&nbsp;&nbsp;&nbsp; Obsessive-compulsive disorder

4.5.1&nbsp;&nbsp;&nbsp; Market size, by region, 2017-2030 (USD Million)

4.6&nbsp;&nbsp;&nbsp; Dystonia

4.6.1&nbsp;&nbsp;&nbsp; Market size, by region, 2017-2030 (USD Million)

4.7&nbsp;&nbsp;&nbsp; Pain management

4.7.1&nbsp;&nbsp;&nbsp; Market size, by region, 2017-2030 (USD Million)

4.8&nbsp;&nbsp;&nbsp; Others

4.8.1&nbsp;&nbsp;&nbsp; Market size, by region, 2017-2030 (USD Million)

Chapter 5&nbsp;&nbsp;&nbsp;Deep Brain Stimulation Devices, By End-use

5.1&nbsp;&nbsp;&nbsp; Key segment trends

5.2&nbsp;&nbsp;&nbsp; Hospitals

5.2.1&nbsp;&nbsp;&nbsp; Market size, by region, 2017-2030 (USD Million)

5.3&nbsp;&nbsp;&nbsp; Ambulatory surgical centers

5.3.1&nbsp;&nbsp;&nbsp; Market size, by region, 2017-2030 (USD Million)

5.4&nbsp;&nbsp;&nbsp; Others

5.4.1&nbsp;&nbsp;&nbsp; Market size, by region, 2017-2030 (USD Million)

Chapter 6&nbsp;&nbsp;&nbsp;Deep Brain Stimulation Devices, By Region

6.1&nbsp;&nbsp;&nbsp; Key regional trends

6.2&nbsp;&nbsp;&nbsp; North America

6.2.1&nbsp;&nbsp;&nbsp; Market size, by country, 2017-2030 (USD Million)

6.2.2&nbsp;&nbsp;&nbsp; Market size, by application, 2017-2030 (USD Million)

6.2.3&nbsp;&nbsp;&nbsp; Market size, by end-use, 2017-2030 (USD Million)

6.2.4&nbsp;&nbsp;&nbsp; U.S.

6.2.4.1&nbsp;&nbsp;&nbsp;Market size, by application, 2017-2030 (USD Million)

6.2.4.2&nbsp;&nbsp;&nbsp;Market size, by end-use, 2017-2030 (USD Million)

6.2.5&nbsp;&nbsp;&nbsp; Canada

6.2.5.1&nbsp;&nbsp;&nbsp;Market size, by application, 2017-2030 (USD Million)

6.2.5.2&nbsp;&nbsp;&nbsp;Market size, by end-use, 2017-2030 (USD Million)

6.3&nbsp;&nbsp;&nbsp; Europe

6.3.1&nbsp;&nbsp;&nbsp; Market size, by country, 2017-2030 (USD Million)

6.3.2&nbsp;&nbsp;&nbsp; Market size, by application, 2017-2030 (USD Million)

6.3.3&nbsp;&nbsp;&nbsp; Market size, by end-use, 2017-2030 (USD Million)

6.3.4&nbsp;&nbsp;&nbsp; Germany

6.3.4.1&nbsp;&nbsp;&nbsp;Market size, by application, 2017-2030 (USD Million)

6.3.4.2&nbsp;&nbsp;&nbsp;Market size, by end-use, 2017-2030 (USD Million)

6.3.5&nbsp;&nbsp;&nbsp; UK

6.3.5.1&nbsp;&nbsp;&nbsp;Market size, by application, 2017-2030 (USD Million)

6.3.5.2&nbsp;&nbsp;&nbsp;Market size, by end-use, 2017-2030 (USD Million)

6.3.6&nbsp;&nbsp;&nbsp; France

6.3.6.1&nbsp;&nbsp;&nbsp;Market size, by application, 2017-2030 (USD Million)

6.3.6.2&nbsp;&nbsp;&nbsp;Market size, by end-use, 2017-2030 (USD Million)

6.3.7&nbsp;&nbsp;&nbsp; Italy

6.3.7.1&nbsp;&nbsp;&nbsp;Market size, by application, 2017-2030 (USD Million)

6.3.7.2&nbsp;&nbsp;&nbsp;Market size, by end-use, 2017-2030 (USD Million)

6.3.8&nbsp;&nbsp;&nbsp; Spain

6.3.8.1&nbsp;&nbsp;&nbsp;Market size, by application, 2017-2030 (USD Million)

6.3.8.2&nbsp;&nbsp;&nbsp;Market size, by end-use, 2017-2030 (USD Million)

6.4&nbsp;&nbsp;&nbsp; Asia Pacific

6.4.1&nbsp;&nbsp;&nbsp; Market size, by country, 2017-2030 (USD Million)

6.4.2&nbsp;&nbsp;&nbsp; Market size, by application, 2017-2030 (USD Million)

6.4.3&nbsp;&nbsp;&nbsp; Market size, by end-use, 2017-2030 (USD Million)

6.4.4&nbsp;&nbsp;&nbsp; Japan

6.4.4.1&nbsp;&nbsp;&nbsp;Market size, by application, 2017-2030 (USD Million)

6.4.4.2&nbsp;&nbsp;&nbsp;Market size, by end-use, 2017-2030 (USD Million)

6.4.5&nbsp;&nbsp;&nbsp; China

6.4.5.1&nbsp;&nbsp;&nbsp;Market size, by application, 2017-2030 (USD Million)

6.4.5.2&nbsp;&nbsp;&nbsp;Market size, by end-use, 2017-2030 (USD Million)

6.4.6&nbsp;&nbsp;&nbsp; India

6.4.6.1&nbsp;&nbsp;&nbsp;Market size, by application, 2017-2030 (USD Million)

6.4.6.2&nbsp;&nbsp;&nbsp;Market size, by end-use, 2017-2030 (USD Million)

6.4.7&nbsp;&nbsp;&nbsp; Australia

6.4.7.1&nbsp;&nbsp;&nbsp;Market size, by application, 2017-2030 (USD Million)

6.4.7.2&nbsp;&nbsp;&nbsp;Market size, by end-use, 2017-2030 (USD Million)

6.5&nbsp;&nbsp;&nbsp; Latin America

6.5.1&nbsp;&nbsp;&nbsp; Market size, by country, 2017-2030 (USD Million)

6.5.2&nbsp;&nbsp;&nbsp; Market size, by application, 2017-2030 (USD Million)

6.5.3&nbsp;&nbsp;&nbsp; Market size, by end-use, 2017-2030 (USD Million)

6.5.4&nbsp;&nbsp;&nbsp; Brazil

6.5.4.1&nbsp;&nbsp;&nbsp;Market size, by application, 2017-2030 (USD Million)

6.5.4.2&nbsp;&nbsp;&nbsp;Market size, by end-use, 2017-2030 (USD Million)

6.5.5&nbsp;&nbsp;&nbsp; Mexico

6.5.5.1&nbsp;&nbsp;&nbsp;Market size, by application, 2017-2030 (USD Million)

6.5.5.2&nbsp;&nbsp;&nbsp;Market size, by end-use, 2017-2030 (USD Million)

6.6&nbsp;&nbsp;&nbsp; Middle East and Africa

6.6.1&nbsp;&nbsp;&nbsp; Market size, by country, 2017-2030 (USD Million)

6.6.2&nbsp;&nbsp;&nbsp; Market size, by application, 2017-2030 (USD Million)

6.6.3&nbsp;&nbsp;&nbsp; Market size, by end-use, 2017-2030 (USD Million)

6.6.4&nbsp;&nbsp;&nbsp; South Africa

6.6.4.1&nbsp;&nbsp;&nbsp;Market size, by application, 2017-2030 (USD Million)

6.6.4.2&nbsp;&nbsp;&nbsp;Market size, by end-use, 2017-2030 (USD Million)

6.6.5&nbsp;&nbsp;&nbsp; Saudi Arabia

6.6.5.1&nbsp;&nbsp;&nbsp;Market size, by application, 2017-2030 (USD Million)

6.6.5.2&nbsp;&nbsp;&nbsp;Market size, by end-use, 2017-2030 (USD Million)

6.6.6&nbsp;&nbsp;&nbsp; UAE

6.6.6.1&nbsp;&nbsp;&nbsp;Market size, by application, 2017-2030 (USD Million)

6.6.6.2&nbsp;&nbsp;&nbsp;Market size, by end-use, 2017-2030 (USD Million)

Chapter 7&nbsp;&nbsp;&nbsp;Company Profiles

7.1&nbsp;&nbsp;&nbsp; Strategy dashboard, 2021

7.2&nbsp;&nbsp;&nbsp; Abbott

7.2.1&nbsp;&nbsp;&nbsp; Financial data

7.2.2&nbsp;&nbsp;&nbsp; Product landscape

7.2.3&nbsp;&nbsp;&nbsp; Strategic outlook

7.2.4&nbsp;&nbsp;&nbsp; SWOT analysis

7.3&nbsp;&nbsp;&nbsp; Boston Scientific

7.3.1&nbsp;&nbsp;&nbsp; Business overview

7.3.2&nbsp;&nbsp;&nbsp; Financial data

7.3.3&nbsp;&nbsp;&nbsp; Product landscape

7.3.4&nbsp;&nbsp;&nbsp; SWOT analysis

7.4&nbsp;&nbsp;&nbsp; Medtronic

7.4.1&nbsp;&nbsp;&nbsp; Business overview

7.4.2&nbsp;&nbsp;&nbsp; Financial data

7.4.3&nbsp;&nbsp;&nbsp; Product landscape

7.4.4&nbsp;&nbsp;&nbsp; Strategic outlook

7.4.5&nbsp;&nbsp;&nbsp; SWOT analysis

7.5&nbsp;&nbsp;&nbsp; Beijing PINS Medical Co. Ltd

7.5.1&nbsp;&nbsp;&nbsp; Business overview

7.5.2&nbsp;&nbsp;&nbsp; Financial data

7.5.3&nbsp;&nbsp;&nbsp; Product landscape

7.5.4&nbsp;&nbsp;&nbsp; SWOT analysis

7.6&nbsp;&nbsp;&nbsp; SceneRay Co., Ltd.

7.6.1&nbsp;&nbsp;&nbsp; Business overview

7.6.2&nbsp;&nbsp;&nbsp; Financial data

7.6.3&nbsp;&nbsp;&nbsp; Product landscape

7.6.4&nbsp;&nbsp;&nbsp; Strategic outlook

7.6.5&nbsp;&nbsp;&nbsp; SWOT analysis 
&nbsp;

Deep Brain Stimulation Devices Market

Get a free sample of this report